Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
26 studies found for:    ocrelizumab
Show Display Options
Rank Status Study
1 Recruiting A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Ocrelizumab
2 Recruiting Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Ocrelizumab
3 Recruiting A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Biological: Ocrelizumab
4 Not yet recruiting Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Ocrelizumab
5 Completed A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Ocrelizumab
6 Recruiting Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
Conditions: Relapsing Multiple Sclerorsis;   Multiple Sclerosis, Primary Progressive
Interventions: Drug: Ocrelizumab;   Procedure: Lumber Puncture
7 Active, not recruiting A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Condition: Multiple Sclerosis, Primary Progressive
Interventions: Drug: Ocrelizumab;   Other: Placebo
8 Completed A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: ocrelizumab
9 Terminated A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Interventions: Drug: Ocrelizumab;   Drug: Placebo
10 Active, not recruiting A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
Condition: Relapsing Multiple Sclerosis
Interventions: Drug: Ocrelizumab;   Drug: Ocrelizumab Placebo;   Drug: Rebif;   Drug: Rebif placebo
11 Active, not recruiting A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
Condition: Relapsing Multiple Sclerosis
Interventions: Drug: Ocrelizumab;   Drug: Ocrelizumab placebo;   Drug: Rebif;   Drug: Rebif placebo
12 Available Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Ocrelizumab
13 Not yet recruiting Tolerability and Safety of Switching From Rituximab to Ocrelizumab in Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Ocrelizumab;   Drug: Rituximab
14 Active, not recruiting
Has Results
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Placebo;   Drug: Ocrelizumab;   Drug: Avonex
15 Terminated A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy
Condition: Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: ocrelizumab;   Drug: placebo
16 Not yet recruiting Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Healthy
Interventions: Other: Blood sampling (MS);   Other: Blood sampling (controls)
17 Not yet recruiting Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab.
Condition: Relapsing Remitting Multiple Sclerosis
Intervention:
18 Terminated A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)
Condition: Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: ocrelizumab;   Drug: placebo
19 Terminated A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)
Condition: Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: ocrelizumab;   Drug: placebo
20 Terminated A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: placebo;   Drug: methotrexate;   Drug: ocrelizumabu 50mg;   Drug: ocrelizumabu 200mg;   Drug: ocrelizumab 500mg

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.